Lazarus Alon has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 27000 shares of Werewolf Therapeutics, Inc. ($HOWL) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Werewolf Therapeutics, Inc. | $HOWL | Lazarus Alon | Not found | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 44,827,159 | 9999.99% | 0.06% |
| May 24, 2024 | Werewolf Therapeutics, Inc. | $HOWL | Lazarus Alon | Not found | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | Werewolf Therapeutics, Inc. | $HOWL | Lazarus Alon | Director | A | Stock Option (right to buy) | 13200 | $0.00 | 13,200.0000 | 0 | 9999.99% | 0.00% |